Cargando…

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant

Composite lymphoma is the rare simultaneous manifestation of two distinct lymphomas. Chronic lymphocytic leukemia (CLL) has a propensity for occurring in composite lymphomas, a phenomenon that remains to be elucidated. We applied cytogenetics, droplet digital polymerase chain reaction, and massively...

Descripción completa

Detalles Bibliográficos
Autores principales: Locher, Maurus, Jukic, Emina, Bohn, Jan‐Paul, Untergasser, Gerold, Steurer, Michael, Cramer, Christian Andreas, Schwendinger, Simon, Vogi, Verena, Verdorfer, Irmgard, Witsch‐Baumgartner, Martina, Nachbaur, David, Gunsilius, Eberhard, Wolf, Dominik, Zschocke, Johannes, Steiner, Normann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984250/
https://www.ncbi.nlm.nih.gov/pubmed/33277788
http://dx.doi.org/10.1002/gcc.22925
Descripción
Sumario:Composite lymphoma is the rare simultaneous manifestation of two distinct lymphomas. Chronic lymphocytic leukemia (CLL) has a propensity for occurring in composite lymphomas, a phenomenon that remains to be elucidated. We applied cytogenetics, droplet digital polymerase chain reaction, and massively parallel sequencing to analyze longitudinally a patient with CLL, who 3 years later showed transformation to a hairy cell leukemia‐variant (HCL‐V). Outgrowth of the IGHV4‐34‐positive HCL‐V clone at the expense of the initially dominant CLL clone with trisomy 12 and MED12 mutation started before CLL‐guided treatment and was accompanied by a TP53 mutation, which was already detectable at diagnosis of CLL. Furthermore, deep sequencing of IGH showed a composite lymphoma with presence of both disease components at all analyzed timepoints (down to a minor clone: major clone ratio of ~1:1000). Overall, our analyses showed a disease course that resembled clonal dynamics reported for malignancies with intratumoral heterogeneity and illustrate the utility of deep sequencing of IGH to detect distinct clonal populations at diagnosis, monitor clonal response to therapy, and possibly improve clinical outcomes.